InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Ainsworth Sean. Director active across 2 companies, notably Opus Genetics, Inc.. In total, 4 disclosures have been recorded. History available since 19 October 2022. The latest transaction was filed on 30 April 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
4 of 4 declarations